Related Experiment Video
Updated: Jun 11, 2026
08:32
Studying the Hypothalamic Insulin Signal to Peripheral Glucose Intolerance with a Continuous Drug Infusion System into the Mouse Brain
Published on: January 4, 2018
Ventral medial hypothalamus: involvement in hypoglycemic convulsions
Science (New York, N.Y.)
|February 28, 1975
Summary
Hypothalamic lesions increase insulin resistance in mice, requiring double the insulin dose to induce convulsions. Even high insulin doses failed to cause seizures in most lesioned mice, despite significant blood glucose reduction.
Area of Science:
- Neuroendocrinology
- Metabolic research
Background:
- The hypothalamus regulates glucose homeostasis and insulin sensitivity.
- Ventral medial hypothalamus (VMH) lesions are known to cause obesity and metabolic disturbances.
Purpose of the Study:
- To investigate the effect of VMH lesions on insulin-induced convulsions.
- To assess changes in insulin sensitivity and glucose regulation following VMH damage.
Main Methods:
- Mice underwent VMH lesions using gold thioglucose.
- Insulin tolerance tests were performed, measuring the dose required for convulsions.
- Blood glucose levels were monitored post-insulin administration.
Main Results:
- Lesioned mice required double the insulin dose for 50% convulsion incidence compared to controls.
- Even maximal insulin doses (50 mU/g) did not induce convulsions in over 60% of lesioned mice.
- Blood glucose levels dropped to ~24 mg/dL in lesioned mice without causing widespread seizures.
Conclusions:
- VMH lesions significantly impair the ability of insulin to induce convulsions.
- This suggests a substantial alteration in glucose regulation and/or insulin sensitivity post-VMH lesion.
- The VMH plays a critical role in mediating insulin's systemic effects, including seizure induction.
More Related Videos
Related Concept Videos
01:16Hormones Regulating Blood Glucose
Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
In addition to accelerating glucose uptake and utilization, insulin has...
01:02Glucose Homeostasis: Regulation of Blood Glucose
Carbohydrates consumed through foods are converted into glucose, a crucial energy source for the body. In the prandial state, high blood glucose levels stimulate the secretion of insulin from the pancreas. Insulin inhibits hepatic glucose production and stimulates glucose uptake and metabolism by muscle and adipose tissue. The excess glucose is converted into glycogen and stored in the liver and muscles.
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
01:15Hypoglycemia and Glucagon
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
01:26Hypoglycemia
Hypoglycemia is a blood glucose level below 70 mg/dL. It commonly occurs in individuals using insulin or insulin-secreting drugs, but may also arise in non-diabetic conditions. People with type 1 diabetes are at the highest risk because they depend on exogenous insulin. People with type 2 diabetes are also at risk, especially when treated with insulin or medications such as sulfonylureas, which increase insulin release regardless of blood glucose levels. It develops when insulin levels exceed...
01:29Hyperglycemia
Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...
01:22Diabetic Neuropathy
DefinitionDiabetic neuropathy is nerve damage caused by long-standing diabetes mellitus. It results directly from prolonged high blood sugar levels.PathophysiologyThe pathophysiology of diabetic neuropathy involves both metabolic and vascular disturbances triggered by chronic hyperglycemia.Metabolic injury: Elevated glucose levels activate the polyol pathway within nerve cells, leading to the accumulation of sorbitol and fructose. This increases oxidative stress, disrupts normal nerve...